Morgan Stanley Downgrades Clarivate to Equal-Weight, Raises Price Target to $12

Morgan Stanley analyst Toni Kaplan downgrades Clarivate (NYSE:CLVT) from Overweight to Equal-Weight and raises the price target from $11 to $12.

Morgan Stanley analyst Toni Kaplan downgrades Clarivate (NYSE:CLVT) from Overweight to Equal-Weight and raises the price target from $11 to $12.

Total
0
Shares
Related Posts